Targeting the Galectin‐7/TRPM2/Zn2+/DRP‐1 Signaling Pathway: A Potential Therapeutic Intervention in the Pathogenesis of SJS/TEN

Documenti analoghi

• Involvement of B Cell Subsets in Patients With Steven Johnson Syndrome/Toxic Epidermal Necrolysis ( SJS / TEN )
  di: Fareed Ahmad, et al.
  Pubblicazione: (2026)
• In chronic spontaneous urticaria, increased Galectin‐9 expression on basophils and eosinophils is linked to high disease activity, endotype‐specific markers, and response to omalizumab treatment
  di: Jiang Ji, et al.
  Pubblicazione: (2024)
• Unveiling Rare Genetic Variants in DAB2IP : New Insights Into the Pathogenesis of Recurrent Angioedema
  di: Maurizio Margaglione, et al.
  Pubblicazione: (2025)
• Potential Protective Role of Galectin‐3 in Airway Dilatation in Obstructive Airway Diseases
  di: Mariko Kogo, et al.
  Pubblicazione: (2025)
• Pathogenesis and Treatment of Atopic Dermatitis: Lessons From China
  di: Xu Yao, et al.
  Pubblicazione: (2025)